Matthew R. Vogt, Ph.D.
|2013||Biology & Biomedical Sciences (Immunology)||Washington University, Saint Louis, St. Louis, MO|
Mean distance: 18.92 (cluster 11)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Vogt MR, Dowd KA, Engle M, et al. (2011) Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms. Journal of Virology. 85: 11567-80|
|Lazear HM, Pinto AK, Vogt MR, et al. (2011) Beta interferon controls West Nile virus infection and pathogenesis in mice. Journal of Virology. 85: 7186-94|
|Kaufmann B, Vogt MR, Goudsmit J, et al. (2010) Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proceedings of the National Academy of Sciences of the United States of America. 107: 18950-5|
|Dunn MD, Rossi SL, Carter DM, et al. (2010) Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice. Virology Journal. 7: 95|
|Zhang S, Vogt MR, Oliphant T, et al. (2009) Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. The Journal of Infectious Diseases. 200: 202-5|
|Vogt MR, Moesker B, Goudsmit J, et al. (2009) Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. Journal of Virology. 83: 6494-507|